In re Gentiva Securities Litigation

2 F. Supp. 3d 384, 2014 U.S. Dist. LEXIS 27825, 2014 WL 814952
CourtDistrict Court, E.D. New York
DecidedMarch 3, 2014
DocketNo. 10-CV-5064 (ADS)(WDW)
StatusPublished
Cited by2 cases

This text of 2 F. Supp. 3d 384 (In re Gentiva Securities Litigation) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Gentiva Securities Litigation, 2 F. Supp. 3d 384, 2014 U.S. Dist. LEXIS 27825, 2014 WL 814952 (E.D.N.Y. 2014).

Opinion

MEMORANDUM OF DECISION AND ORDER

SPATT, District Judge.

Familiarity with the facts and procedural history of this case is presumed. By way of background, this is a consolidated securities fraud class action brought on behalf of a class consisting of all persons or entities that purchased the publicly traded securities of Gentiva Health Services, Inc. (“Gentiva”) between July 31, 2008 and October 4, 2011. The amended consolidated class action complaint was filed by the Lead Plaintiff the Los Angeles City Employees’ Retirement System (the “Plaintiff’). According to the Plaintiff, Gentiva, a publicly traded health care provider, artificially inflated its stock price through a scheme that involved ordering unnecessary medical care for clients, and then billing the federal government for these illegitimate expenses. The complaint further alleges that when the scheme came to light, Gentiva’s stock price dropped precipitously.

The Individual Defendants originally joined are current and/or former directors and/or officers of the company. Ronald A. Malone previously served as Gentiva’s Chief Executive Officer from June 2002 until December 2008, and as Chairman of the Board of Directors until May 2011. H. Anthony Strange served as Gentiva’s President beginning in 2007, and served as its Chief Operating Officer from November 2007 through May 2009. Strange then became the company’s Chief Executive Officer in January 2009, and its Chairman in May 2011. John R. Potapchuck served as Gentiva’s Chief Financial Officer and Treasurer until May 2010. He was succeeded in May 2010 by Eric R. Slusser, who currently serves as the company’s Chief Financial Officer, Treasurer, and Executive Vice President.

On March 25, 2013, the Court dismissed the Plaintiffs original consolidated class action complaint in its entirety. In re Gentiva Sec. Litig., 932 F.Supp.2d 352 [386]*386(E.D.N.Y.2013) (Spatt, J.). In particular, the Court dismissed with prejudice the Plaintiffs claims under §§ 11 and 15 of the Securities Act of 1933 (the “1933 Act”) for lack of standing and for failure to state a claim. The Court also dismissed without prejudice the Plaintiffs claims under §§ 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “1934 Act”) and Rule 10b-5 promulgated thereunder, for failure to plead scienter.

On May 10, 2013, the Plaintiff filed an amended consolidated class action complaint, amending only those allegations relevant to the element of scienter. On June 24, 2013, the Defendants moved pursuant to Federal Rule of Civil Procedure (“Fed. R. Civ.P.”) 12(b)(6) to dismiss the amended consolidated class action complaint for failure to state a claim.

On September 19, 2013, the Court granted in part and denied in part the second motion to dismiss. In re Gentiva Sec. Litig., 932 F.Supp.2d 352 (E.D.N.Y.2013). Of relevance here, the Court granted the motion to dismiss the amended consolidated class action complaint as to the Defendants Strange and Slusser in its entirety, and as against the Defendants Malone and Potapchuck to the extent the Plaintiffs sought to establish their scienter based on a theory of conscious behavior and recklessness. However, the Court denied the motion to dismiss to the extent the Plaintiff sought to establish scienter on the part of Malone and Potapchuk based on a theory of motive and opportunity. In doing so, the Court relied on allegations regarding insider stock sales by Malone and Potap-chuck during the class period.

The Court also denied the motion to dismiss as to Gentiva because the Court concluded that corporate scienter could be inferred from the “suspicious” insider stock sales by both Malone and Potaphuck. The Court further held that the Plaintiff stated a claim for control person liability under Section 20(a) of the 1934 Act as against Malone and Potapchuck.

At that point, the remaining claims were the Section 10(b) claims against Gentiva, Malone, and Potapchuk and the Section 20(a) claims against Malone and Potap-chuk.

On October 3, 2013, Gentiva, Malone, and Potapchuck moved, pursuant to Rule 6.3 of the Local Rules of the United States District Court of the Southern and Eastern District, for partial reconsideration of the September 19, 2013 order. The Plaintiff opposed the motion for partial reconsideration.

On December 10, 2013, the Court granted in part and denied in part the motion for partial reconsideration. In particular, the Court granted the motion to the extent it dismissed all the remaining claims against Potapchuck and Gentiva, but denied the motion with respect to the remaining claims against Malone.

The Plaintiff concedes that, as Malone is the only remaining defendant, it is not possible to plead the Section 20(a) claim for control person liability.

Therefore, currently the only pending cause of action is the Section 10(b) claim against Malone.

On January 9, 2014, Malone answered the amended consolidated class action complaint. The Court notes that there has been no case management conference or case management order, and no formal discovery has taken place.

On January 28, 2014, the Plaintiff moved pursuant to Fed. R. Civ. 54(b) for an order entering final judgment in favor of the relevant defendants for the claims brought under (1) the 1933 Act against all the Defendants and (2) the 1934 Act as to Gentiva, Strange, Potapchuck, and Slusser. [387]*387The Plaintiff argues that delaying entry of judgment would run the risk that the parties would be subject to two rounds of discovery and two trials. For the following reasons, the motion is granted in part and denied in part.

I. DISCUSSION

“[I]n the federal district courts, the entry of a final judgment is generally appropriate ‘only after all claims have been adjudicated.’ ” Novick v. AXA Network, LLC, 642 F.3d 304, 310 (2d Cir.2011) (quoting Harriscom Svenska AB v. Harris Corp., 947 F.2d 627, 629 (2d Cir.1991)). Rule 54(b) of the Federal Rules of Civil Procedure provides “an exception to this general principle,” id., permitting a district court to “direct entry of a final judgment as to one or more, but fewer than all, claims or parties,” but “only if the court expressly determines that there is no just reason for delay.” Fed.R.Civ.P. 54(b). However, the Second Circuit has counseled that the historic “policy against piecemeal appeals ‘requires that the court’s power to enter such a final judgment before the entire case is concluded ... be exercised sparingly.’ ” Novick, 642 F.3d at 310 (quoting Harriscom Svenska AB, 947 F.2d at 629).

“[C'jertification under Rule 54(b) should be granted only if there are interests of sound judicial administration and efficiency to be served or, in the infrequent harsh case where there exists some danger of hardship or injustice through delay which would be alleviated by immediate appeal.” Hogan v. Consol. Rail Corp., 961 F.2d 1021, 1025 (2d Cir.1992) (citations, alterations, and internal quotation marks omitted).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
2 F. Supp. 3d 384, 2014 U.S. Dist. LEXIS 27825, 2014 WL 814952, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-gentiva-securities-litigation-nyed-2014.